In vivo effect of celecoxib and tenoxicam on oxidant/anti-oxidant status of patients with knee osteoarthritis

Annals of Clinical and Laboratory Science

Volumn 35, Issue 2, 2005, Pages 137-143

  Ozgocmen, Salih ^a,d   Ardicoglu, Ozge ^a   Erdogan, Hasan ^b   Fadillioglu, Ersin ^c   Gudul, Huseyin ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b GAZIOSMANPASA UNIVERSITY   (Turkey)

^c INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^d FIRAT UNIVERSITY   (Turkey)

Author keywords

Celecoxib; Free radicals; Nitric oxide; Osteoarthritis; Oxidative stress; Tenoxicam

Indexed keywords

ANTIOXIDANT; CELECOXIB; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE; NITRITE; OXIDIZING AGENT; SUPEROXIDE DISMUTASE; TENOXICAM; XANTHINE OXIDASE;

ADULT; ANALGESIA; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; IN VIVO STUDY; JOINT STIFFNESS; KNEE OSTEOARTHRITIS; LIPID PEROXIDATION; MALE; OUTCOMES RESEARCH; OXIDATIVE STRESS; PAIN; PAIN ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

ADULT; AGED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OSTEOARTHRITIS, KNEE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PIROXICAM; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; REACTIVE OXYGEN SPECIES; SULFONAMIDES;

EID: 18744384078     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Lunec J, Halloran SP, White AG, Dormandy TL. Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 1981;8:233-245.
2. Akyol O, Isci N, Temel I, Ozgocmen S, Uz E, Murat M, Buyukberber S. The relationships between plasma and erythrocyte antioxidant enzymes and lipid peroxidation in patients with rheumatoid arthritis. Joint Bone Spine 2001;68:311-317.
3. Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O. Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 2004;24:80-83.
4. Henrotin YE, Bruckner P, Pujol JPL. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 2003;11:747-755.
5. Del Carlo M, Loeser RF. Increased oxidative stress with aging reduces chondrocyte survival: Correlation with intracellular glutathione levels. Arthritis Rheum 2003;48:3419-3430.
6. Del Carlo M, Loeser RF. Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum 2002;46:394-403.
7. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 3rd ed. Clarendon Press, Oxford, 1999.
8. Fosslien E. Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system. Ann Clin Lab Sci 1998;28:67-81.
9. Vane JR, Botting RM. Mechanism of action of nosteroidal anti-inflammatory drugs. Am J Med 1998;104;2S-8S.
10. Lane NE. Pain management in osteoarthritis: The role of COX-2 inhibitors. J Rheumatol 1997;24(Suppl 49);20-24.
11. Hinz B, Brune K. Pain in osteoarthritis: new drug and mechanisms. Curr Opin Rheumatol 2004;16:628-633.
12. Maffei Facino RM, Carini M, Saibene L. Scavenging of free radicals by tenoxicam: a participating mechanism in the antirheumatic/anti-inflammatory efficacy of the drug. Arch Pharm 1996:329;457-463.
13. Parij N, Nagy AM, Fondu P, Neve J. Effects of non-steroidal anti-inflammatory drugs on the luminol and lucigenin amplified chemiluminescence of human neutrophils. Eur J Pharmacol 1998;352:299-305.
14. Van Antwerpen P, Neve J. In vitro comparative assessment of the scavenging activity against three reactive oxygen species of non-steroidal anti-inflammatory drugs from oxicam and sulfonilide families. Eur J Pharm 2004;496;55-61.
15. Facino RM, Carini M, Aldini G. Antioxidant activity of nimesulide and its main metabolites. Drugs 1993;46(Suppl 1):15-21.
16. Cimen MYB, Bolgen-Cimen O, Eskandari G, Sahin G, Erdogan C, Atik U. In vivo effects of meloxicam, celecoxib and ibuprofen on free radical metabolism in human erythrocytes. Drug Chem Toxicol 2003;26:169-176.
17. Zheng SX, Mouithys-Mickalad A, Deby-Dupont GP, Deby CM, Maroulis AP, Labasse AH, Lamy ML, Crielaard JM, Reginster JY, Henrotin YE. In vitro study of the antioxidant properties of nimesulide and 4-OH nimesulide: effects on HRP- and luminol-dependent chemiluminescence produced by human chondrocytes. Osteoarthritis Cartilage 2000;8:419-425.
18. Mouithys-Mickalad AM, Zheng SX, Deby-Dupont GP, Deby CM, Lamy MM, Reginster JY, Henrotin YE. In vitro study of the antioxidant properties of non steroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR). Free Radic Res 2000;33:607-621.
19. Basivireddy J, Jacob M, Pulimood AB, Balasubramanian KA. Indomethacin-induced renal damage: role of oxygen free radicals. Biochem Pharmacol 2004;67:587-599.
20. Nakamura Y, Kozuka M, Naniwa K, Takabayashi S, Torikai K, Hayashi R, Sato T, Ohigashi H, Osawa T. Arachidonic acid cascade inhibitors modulate phorbol ester-induced oxidative stress in female ICR mouse skin: differential roles of 5-lipoxygenase and cyclooxygenase-2 in leukocyte infiltration and activation. Free Radic Biol Med 2003;35:997-1007.
21. Altman RD, Asch E, Bloch D, Bole G, et al. Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-1049.
22. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-1840.
23. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. In: Oxygen Radicals in Biological Systems (Packer L, Glazer AN, Eds), Method Enzymol 1990;186:407-421.
24. Cortas NK, Wakid NW Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440-1443.
25. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500.
26. Prajda N, Weber G. Malign transformation-linked imbalance: decreased XO activity in hepatomas. FEBS Lett 1975;59:245-249.
27. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-170.
28. Colli S, Colombo S, Tremoli E, Stragliotto E, Nicosia S. Effects of tenoxicam on superoxide anion formation, beta-glucuronidase release and fMLP binding in human neutrophils: comparison with other NSAIDs. Pharmacol Res 1991;23:367-379.
29. 2 produces novel products. Drug Metab Dispos 1989;17:463-468.
30. Orhan H, Sahin G. In vitro effects of NSAIDS and paracetamol on oxidative stress-related parameters of human erythrocytes. Exp Toxicol Pathol 2001;53:133-140.
31. Akyol O, Herken H, Uz E, Fadillioglu E, Unal S, Sogut S, Ozyurt H, Savas HA. The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog Neuropsychopharmacol Biol Psychiatr 2002,26:995-1005.
32. Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum 1998;41:1141-1151.
33. Lotz M. The role of nitric oxide in articular cartilage damage. Rheum Dis Clin North Am 1999;25:269-282.
34. Karan A, Karan MA, Vural P, Erten N, Tascioglu C, Aksoy C, Canbaz M, Oncel A. Synovial fluid nitric oxide levels in patients with knee osteoarthritis. Clin Rheumatol 2003;22:397-399.
35. Pelletier JP, Lascou-Coman V, Jovanovic D, Fernandes JC, Manning P, Connor JR, et al. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol 1999;26:2002-2014.
36. Takabashi T, Uemura Y, Tagushi H, Ogawa Y, Yashida S, Toda M, Kobayashi T, Seguchi H, Tani T. Cross talk between COX-2 inhibitor and hyaluronic acid in osteoarthritis chondrocytes. Int J Mol Med 2004;14:139-144.
37. Jovanovic DV, Mineau F, Notoya K, Reboul P, Martel-Pelletier J, Pelletier JP. Nitric oxide induced cell death in human osteoarthritic synoviocytes is mediated by tyrosine kinase activation and hydrogen peroxide and/or superoxide formation. J Rheumatol 2002;29:2165-2175.
38. Yoon YB, Kim SJ, Hwang SG, et al. Non-steroidal anti-inflammatory drugs inhibit nitric oxide induced apoptosis and differentiation of articular chondrocytes independent of cyclooxygenase activity. J Biol Chem 2003;278:15319-15325.